Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer
Article in Clinical and Translational Radiation Oncology (November 2023)
The most recent citing publication is shown below. View this citation on Dimensions.